XML 116 R102.htm IDEA: XBRL DOCUMENT v3.20.4
SHARE-BASED COMPENSATION PROGRAMS - Restricted and Performance Stock Activity (Details)
12 Months Ended
Dec. 31, 2020
$ / shares
shares
Holdings Restricted Stock | Restricted Stock Unit Awards  
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward]  
Unvested, Beginning Balance (in shares) | shares 1,805,301
Granted (in shares) | shares 994,290
Forfeited (in shares) | shares (117,353)
Vested (in shares) | shares (629,202)
Unvested, Ending Balance (in shares) | shares 2,053,036
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract]  
Unvested, Beginning Balance, Weighted Average Grant Date Fair Value (in dollars per share) | $ / shares $ 19.35
Granted, Weighted Average Grant Date Fair Value (in dollars per share) | $ / shares 22.85
Forfeited, Weighted Average Grant Date Fair Value (in dollars per share) | $ / shares 20.36
Vested, Weighted Average Grant Date Fair Value (in dollars per share) | $ / shares 19.81
Unvested, Ending Balance, Weighted Average Grant Date Fair Value (in dollars per share) | $ / shares $ 21.15
Holdings Restricted Stock | Performance Shares  
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward]  
Unvested, Beginning Balance (in shares) | shares 383,641
Granted (in shares) | shares 225,674
Forfeited (in shares) | shares (51,860)
Vested (in shares) | shares 0
Unvested, Ending Balance (in shares) | shares 557,455
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract]  
Unvested, Beginning Balance, Weighted Average Grant Date Fair Value (in dollars per share) | $ / shares $ 21.05
Granted, Weighted Average Grant Date Fair Value (in dollars per share) | $ / shares 23.92
Forfeited, Weighted Average Grant Date Fair Value (in dollars per share) | $ / shares 21.97
Vested, Weighted Average Grant Date Fair Value (in dollars per share) | $ / shares
Unvested, Ending Balance, Weighted Average Grant Date Fair Value (in dollars per share) | $ / shares $ 22.12
AXA Restricted Stock | Restricted Stock Unit Awards  
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward]  
Unvested, Beginning Balance (in shares) | shares 19,280
Granted (in shares) | shares 0
Forfeited (in shares) | shares 0
Vested (in shares) | shares (19,280)
Unvested, Ending Balance (in shares) | shares 0
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract]  
Unvested, Beginning Balance, Weighted Average Grant Date Fair Value (in dollars per share) | $ / shares $ 19.20
Granted, Weighted Average Grant Date Fair Value (in dollars per share) | $ / shares 0
Forfeited, Weighted Average Grant Date Fair Value (in dollars per share) | $ / shares 0
Vested, Weighted Average Grant Date Fair Value (in dollars per share) | $ / shares 19.20
Unvested, Ending Balance, Weighted Average Grant Date Fair Value (in dollars per share) | $ / shares $ 0
AXA Restricted Stock | Performance Shares  
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward]  
Unvested, Beginning Balance (in shares) | shares 2,154,059
Granted (in shares) | shares 0
Forfeited (in shares) | shares (62,493)
Vested (in shares) | shares (1,074,313)
Unvested, Ending Balance (in shares) | shares 1,017,254
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract]  
Unvested, Beginning Balance, Weighted Average Grant Date Fair Value (in dollars per share) | $ / shares $ 20.08
Granted, Weighted Average Grant Date Fair Value (in dollars per share) | $ / shares 0
Forfeited, Weighted Average Grant Date Fair Value (in dollars per share) | $ / shares 20.74
Vested, Weighted Average Grant Date Fair Value (in dollars per share) | $ / shares 18.91
Unvested, Ending Balance, Weighted Average Grant Date Fair Value (in dollars per share) | $ / shares $ 21.28